CEBPA and acute myeloid leukemia: Although CEBPA mutations are frequently observed in AML patients and are associated with sensitivity to chemotherapy [25], and a better prognosis compared to CEBPA wild-type AML patients [26], there are limited reports on CEBPA in AA.